BioFoam® Surgical Matrix


BioFoam Surgical Matrix is a unique, dual-action sealant and hemostat.  BioFoam is delivered as a liquid and sets as a soft foam in seconds.  Its expansion and viscosity properties are optimized to assist with controlled delivery into difficult-to-access spaces.  

BioFoam is indicated for use on both cardiovascular and abdominal parenchymal tissue.1

Derived from CryoLife’s protein hydrogel technology
• used with BioGlue, which has 15+ years of clinical application in over 750,000 procedures
• flexible and pliable hydrogel foam after polymerization
• biocompatible and biodegradable

Simple, ergonomic design allows for unmatched ease of use
• room temperature storage
• off the shelf and ready to use with no preparation or mixing required
• no manual compression needed

Assists in the control of bleeding
• begins polymerizing immediately on application and adhering to the target site
• remains flexible and conforms to irregular tissue
• more than 3 times stronger than fibrin sealants
• controls bleeding independently of the patient's coagulopathic state
• can be applied during cardioplegia (10°-20°C)

icon-info Request More Information


1 BioFoam is not approved for commercial distribution in the U.S.A
2  BioFoam Post-Market Study (BFM0901) Final Results. CryoLife, Inc. Data on File.

BioFoam is not approved for commercial distribution in the following countries: Japan, Peoples Republic of China, USA

Almost all medical devices and products must go through clinical studies and regulatory reviews before they are commercially released, with different countries having different requirements before a product is approved for market. In this section, we have included a number of products that are available in certain countries and not yet available in the United States.